Steris Plc stock dividend – STERIS PLC Declares Quarterly Interim Dividend of $0.47 Per Share, Yielding 0.44%

Trending News ☀️

Steris Plc stock dividend – STERIS PLC ($NYSE:STE), a global leader in infection prevention, contamination control, and surgical and critical care technologies, recently announced a quarterly interim dividend of $0.47 per share. This dividend will be payable on March 23 to shareholders of record as of February 24, with an ex-dividend date of February 23, and has a forward yield of 0.44%. STERIS PLC is a leading provider of medical products, services and technologies that aim to protect patients and healthcare workers from infections and other medical risks. They offer products and services for the prevention of infection, contamination control, operational efficiency and more. Its portfolio includes sterilization systems, surgical tables, patient care products, infection prevention products, and more. STERIS PLC also provides onsite and remote services, such as maintenance and validation services, training, repairs and consulting services.

STERIS PLC is headquartered in Mentor, Ohio and has operations throughout the United States, Europe and Asia Pacific. For more information about the quarterly interim dividend from STERIS PLC, interested investors can visit Seeking Alpha’s STE Dividend Scorecard, Yield Chart and Dividend Growth. This information will provide investors with an overview of the company’s dividend history, yield and growth rate. The quarterly interim dividend from STERIS PLC reflects the company’s commitment to creating value for its shareholders. The board of directors believes that this dividend is a good use of available cash and will help to create long-term shareholder value.

Dividends – Steris Plc stock dividend

This is the latest addition to the company’s dividend offering, which has steadily increased over the last three years. These dividend yields from 2021 to 2023 are expected to be 0.77%, 0.78%, and 0.92%, respectively, with an average dividend yield of 0.82%. The quarterly interim dividend of $0.47 per share is sure to attract investors and shareholders alike who are looking to benefit from the company’s healthy financials. With its dividend offerings increasing, it is likely that STERIS PLC will continue to be a stable and reliable investment for those looking for a steady income.

It is a testament to the financial health and stability of the company that it can afford to pay out such a generous dividend. With its attractive dividend yield, STERIS PLC is sure to continue to be a lucrative investment for many in the years to come.

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Steris Plc. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Steris Plc. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Steris Plc. More…

Key Ratios Snapshot

Some of the financial key ratios for Steris Plc are shown below. More…

Share Price

This news drove the stock price up 3.9%, as it opened at $206.4 and closed at $214.5, up from the previous day’s closing price of 206.5. The dividend was declared in accordance with the Company’s dividend policy, which was recently approved by the Board of Directors. The Board has the discretion to determine the amount and timing of future dividend payments. STERIS PLC is a leading provider of infection prevention and other procedural products and services. The Company operates in three segments: Healthcare Products and Services, Life Sciences, and Healthcare Specialty Services. The Healthcare Products and Services segment provides medical devices and related products and services to healthcare facilities; the Life Sciences segment provides sterilization products and services, laboratory services, and tissue processing services; and the Healthcare Specialty Services segment provides specialized healthcare services, such as sterilization monitoring, cleaning validation, and other services.

The announcement of the interim dividend is part of a larger effort by STERIS PLC to return value to shareholders. This dividend will support shareholders in the near-term while the Company continues to focus on long-term growth initiatives. This dividend will provide shareholders with a small but steady return on their investment in the Company while STERIS PLC continues to focus on its long-term growth initiatives. Live Quote…

Analysis – Steris Plc Intrinsic Value Calculator

GoodWhale has conducted an analysis of STERIS PLC‘s fundamentals, and the fair value of its share is estimated to be around $227.4. This was determined using GoodWhale’s proprietary Valuation Line, which combines a wide range of analytical techniques to calculate the intrinsic value of a stock. Currently, STERIS PLC stock is traded at $214.5, which is a fair price that is undervalued by 5.7%. This indicates that STERIS PLC is a good opportunity for investors who are looking to buy and hold a stock for a long-term return. The analysis conducted by GoodWhale suggests that STERIS PLC is a financially sound company with strong fundamentals. Its financial performance is stable, indicating that it will continue to deliver returns in the future. Additionally, the company’s management team is highly experienced, and their strategies are suitable for the current environment. Overall, the analysis conducted by GoodWhale suggests that STERIS PLC is a safe investment with potential for growth in the future. Thus, it is a good opportunity for investors interested in buying and holding a stock for long-term gains. More…

Peers

The company’s main competitors are Fonar Corp, Stryker Corp, and Dynatronics Corp.

– Fonar Corp ($NASDAQ:FONR)

Fonar Corporation is a holding company, which engages in the design, manufacture, sale, and service of magnetic resonance imaging (MRI) scanners. It operates through the following segments: Upright Multi-Position MRI; Stand-Up MRI; and Recurring Revenue. The Upright Multi-Position MRI segment designs, manufactures, and sells Upright Multi-Position MRI scanners. The Stand-Up MRI segment designs, manufactures, sells, and services Stand-Up MRI scanners. The Recurring Revenue segment provides service contracts, technical support, and parts sales. The company was founded by Stanley C. Krulick in 1978 and is headquartered in Melville, NY.

– Stryker Corp ($NYSE:SYK)

Stryker Corporation is one of the world’s leading medical technology companies. It offers a wide range of medical devices and services, including orthopedics, neurotechnology, and medical imaging. It has more than 87,000 employees worldwide.

– Dynatronics Corp ($NASDAQ:DYNT)

Dynatronics Corp is a medical device company that manufactures and markets physical therapy products and solutions. The company’s products are used by physical therapists, occupational therapists, athletic trainers, and other healthcare professionals. Dynatronics Corp has a market cap of 8.73M as of 2022, a Return on Equity of -10.7%. The company’s products are sold in the United States and internationally.

Summary

STERIS PLC is a healthcare company that recently declared a quarterly interim dividend of $0.47 per share, yielding 0.44%. This dividend is a positive sign of the company’s financial health and indicates that profits are being distributed to shareholders. The stock price has also risen in response to the dividend announcement, indicating that investors are confident in the company’s future prospects. Despite this positive news, investors should always conduct their own research before investing in any company.

This includes analyzing the company’s financials, looking at both past and future performance, and examining the overall market conditions. With good due diligence, investors can make informed decisions and potentially benefit from STERIS PLC’s excellent financial position and prospects for future growth.